Comparison Between Two Rates of Activation of Miniscrew-Supported Upper Jaw Expander in Adolescents

Sponsor
Alexandria University (Other)
Overall Status
Completed
CT.gov ID
NCT04225637
Collaborator
(none)
30
1
2
27
1.1

Study Details

Study Description

Brief Summary

Miniscrew-supported maxillary expanders provide advantages over conventional tooth-supported expanders. However, there is no consensus in the literature regarding their activation protocol. The purpose of the clinical trial is to evaluate and compare the effects of slow and rapid activation rates of miniscrew-supported expanders on the skeletal changes, dento-alveolar changes and the pain experience.

Condition or Disease Intervention/Treatment Phase
  • Device: Miniscrew-Supported Maxillary Expander- Slow activation
  • Device: Miniscrew-Supported Maxillary Expander- Rapid activation
N/A

Detailed Description

Transverse maxillary deficiency is one of the problems that are commonly encountered in the orthodontic practice. Miniscrew-supported maxillary expansion represents a promising modality for the treatment of transverse maxillary deficiency. However, controversies still exist regarding the activation protocol. One of these controversies is whether using a slow activation protocol would be more beneficial to the patients compared to a rapid activation protocol. Another question that consequently ensues is whether such activation protocol would result in less pain compared to the rapid activation protocol.

The null hypothesis of the current study is that there is no difference between slow and rapid activation protocols of miniscrew-supported expander.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison Between Two Activation Protocols of Miniscrew-Supported Maxillary Expander in Adolescents: A Randomized Controlled Clinical Trial
Actual Study Start Date :
Mar 1, 2019
Actual Primary Completion Date :
Apr 28, 2021
Actual Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Slow maxillary expansion

The miniscrew-supported maxillary expander is activated by turning the expansion screw once every other day.

Device: Miniscrew-Supported Maxillary Expander- Slow activation
A maxillary expander is supported on 4 palatal miniscrews. The appliance is activated slowly by turning the expansion screw once every other day to correct the transverse maxillary deficiency.

Experimental: Rapid maxillary expansion

The miniscrew-supported maxillary expander is activated by turning the expansion screw twice daily.

Device: Miniscrew-Supported Maxillary Expander- Rapid activation
A maxillary expander is supported on 4 palatal miniscrews. The appliance is activated rapidly by turning the expansion screw twice per day to correct the transverse maxillary deficiency.

Outcome Measures

Primary Outcome Measures

  1. Transverse skeletal changes from baseline to an average of 5 months after the initial activation, measured using cone beam computed tomography (CBCT) [At baseline and an average of 5 months after the initial activation]

    The data from CBCT scans at the different time points will be exported in Digital Imaging and Communications in Medicine (DICOM) format and processed using suitable software. The relevant landmarks will be defined and located by the investigator to measure the transverse skeletal changes in mm from baseline to the end of passive retention of the expansion.

  2. Dento-alveolar inclination changes from baseline to an average of 5 months after the initial activation, measured using CBCT [At baseline and an average of 5 months after the initial activation]

    The data from CBCT scans at the different time points will be exported in DICOM format and processed using suitable software. The relevant landmarks will be defined and located by the investigator to measure the changes in dento-alveolar inclination from baseline to the end of passive retention of the expansion.

Secondary Outcome Measures

  1. Pain score on Numeric Rating Scale (NRS) at baseline [Baseline]

    Measures pain and how it affects the daily activities on a NRS where each respondent selects a whole number, between 0 and 10, with 0 being the lowest extreme and 10 being the highest extreme.

  2. Pain score on NRS after the first activation of the maxillary expander [On day 1 after the first activation of the maxillary expander]

    Measures pain and how it affects the daily activities on a NRS where each respondent selects a whole number, between 0 and 10, with 0 being the lowest extreme and 10 being the highest extreme.

  3. Pain score on NRS after 1 week of activation of the maxillary expander [After 1 week of activation of the maxillary expander]

    Measures pain and how it affects the daily activities on a NRS where each respondent selects a whole number, between 0 and 10, with 0 being the lowest extreme and 10 being the highest extreme.

  4. Pain score on NRS after the last activation of the maxillary expander [At the end of active expansion (an estimated average of 2 to 3 weeks in the rapid expansion group, and 7 to 12 weeks in the slow expansion group)]

    Measures pain and how it affects the daily activities on a NRS where each respondent selects a whole number, between 0 and 10, with 0 being the lowest extreme and 10 being the highest extreme.

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Permanent dentition.

  • Participants indicated for skeletal maxillary expansion due to unilateral or bilateral posterior cross bite or maxillary transverse deficiency

  • Good oral hygiene

Exclusion Criteria:
  • History of previous orthodontic or orthopedic treatment

  • History of maxillary trauma

  • Patients with congenital craniofacial malformations

  • Patients receiving pharmacological agents or having systemic diseases that might affect the bone metabolism or the pain response

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Dentistry, Alexandria University Alexandria Egypt

Sponsors and Collaborators

  • Alexandria University

Investigators

  • Principal Investigator: Yomna M Yacout, BDS, MSc, Alexandria University
  • Study Chair: Nadia M El Harouni, BDS,MSc,PhD, Alexandria University
  • Study Chair: Essam M Abdallah, BDS,MSc,PhD, Alexandria University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Yomna Mohamed Mohamed Yacout, Assistant lecturer, Alexandria University
ClinicalTrials.gov Identifier:
NCT04225637
Other Study ID Numbers:
  • 01012019
First Posted:
Jan 13, 2020
Last Update Posted:
Jun 21, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yomna Mohamed Mohamed Yacout, Assistant lecturer, Alexandria University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 21, 2021